{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:04:43Z","timestamp":1790838283282,"version":"4.1.0"},"reference-count":28,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,4,1]]},"abstract":"<jats:p>Objective. Intent-to-treat analyses of the Multimodal Treatment Study of ADHD (MTA) revealed group differences on attention-deficit\/hyperactivity disorder symptoms ratings, with better outcome in groups of participants who were assigned the medication algorithm\u2014medication alone (MedMgt) and combined (Comb)\u2014than in those who were not\u2014behavior modification (Beh) alone and community comparison (CC). However, the effect size was reduced by 50% from the end of treatment to the first follow-up. The convergence of outcomes suggests differential changes by treatment group beween 14 and 24 months, which this report explores, both for benefits of treatment and for side effects on growth.<\/jats:p>\n               <jats:p>Methods. We documented reported medication use at 14- and 24-month assessments and formed 4 naturalistic subgroups (Med\/Med, Med\/NoMed, NoMed\/Med, and NoMed\/NoMed). Then we performed exploratory mediator analyses to evaluate effects of changes in medication use on 14- to 24-month change scores of effectiveness (symptom ratings) and growth (height and weight measures).<\/jats:p>\n               <jats:p>Results. The randomly assigned groups with the greatest improvement at the end of the treatment phase (Comb and MedMgt) deteriorated during the follow-up phase, but the other 2 groups (Beh and CC) did not. There were no significant differences in the 14- to 24-month growth rates among the randomly assigned groups, in contrast to significant growth suppression in the Comb and MedMgt at the end of the treatment phase. Changes in medication use mediated the 14- to 24-month change in attention-deficit\/hyperactivity disorder symptom ratings: the subgroup that reported stopping medication (Med\/NoMed) showed the largest deterioration, the subgroup that consistently reported (Med\/Med) or never reported (NoMed\/NoMed) medication use showed modest deterioration, and the subgroup that reported starting medication (NoMed\/Med) showed improvement. Changes in medication use also mediated growth effects: the subgroup that consistently reported medication use (Med\/Med) showed reduced height gain compared with the subgroup that never reported medication use (NoMed\/NoMed), which actually grew faster than predicted by population norms.<\/jats:p>\n               <jats:p>Conclusion. In the MTA follow-up, exploratory naturalistic analyses suggest that consistent use of stimulant medication was associated with maintenance of effectiveness but continued mild growth suppression.<\/jats:p>","DOI":"10.1542\/peds.113.4.762","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:53:04Z","timestamp":1092444784000},"page":"762-769","source":"Crossref","is-referenced-by-count":341,"title":["National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: Changes in Effectiveness and Growth After the End of Treatment"],"prefix":"10.1542","volume":"113","author":[{"name":"MTA Cooperative Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2004,4,1]]},"reference":[{"key":"2021121006145907500_R1","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed (DSM-IV). Washington, DC: American Psychiatric Association; 1994"},{"key":"2021121006145907500_R2","doi-asserted-by":"crossref","unstructured":"MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for ADHD. Arch Gen Psychiatry1999;56:1073\u20131086","DOI":"10.1001\/archpsyc.56.12.1073"},{"key":"2021121006145907500_R3","doi-asserted-by":"crossref","unstructured":"MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit \/hyperactivity disorder. Arch Gen Psychiatry1999;56:1088\u20131096","DOI":"10.1001\/archpsyc.56.12.1088"},{"key":"2021121006145907500_R4","doi-asserted-by":"crossref","unstructured":"Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry.2001;40:168\u2013179","DOI":"10.1097\/00004583-200102000-00011"},{"key":"2021121006145907500_R5","unstructured":"Abikoff H, Hechtman L, Klein RG, et al. Symptomatic improvement in children with ADH treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry. In press"},{"key":"2021121006145907500_R6","doi-asserted-by":"crossref","unstructured":"Paternite CE, Loney J, Salisbury H, Whaley MA. Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes. J Child Adolesc Psychopharmacol.1999;9:169\u2013184","DOI":"10.1089\/cap.1999.9.169"},{"key":"2021121006145907500_R7","doi-asserted-by":"crossref","unstructured":"Gillberg C, Melander H, von Knorring AL, et al. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry.1997;54:857\u2013864","DOI":"10.1001\/archpsyc.1997.01830210105014"},{"key":"2021121006145907500_R8","unstructured":"Greenhill LL, the MTA Cooperative Group. Effects of stimulants on growth rates of children with ADHD in a multisite trial. Poster presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 2000; Chicago, IL"},{"key":"2021121006145907500_R9","doi-asserted-by":"crossref","unstructured":"Safer D, Allen R, Barr E. Growth rebound after termination of stimulant drugs. J Pediatr.1975;86:113\u2013116","DOI":"10.1016\/S0022-3476(75)80720-7"},{"key":"2021121006145907500_R10","doi-asserted-by":"crossref","unstructured":"Gittelman-Klein R, Landa B, Mattes JA, Klein DF. Methylphenidate and growth in hyperactive children. Arch Gen Psychiatry.1988;45:1127\u20131130","DOI":"10.1001\/archpsyc.1988.01800360075011"},{"key":"2021121006145907500_R11","doi-asserted-by":"crossref","unstructured":"Satterfield JH, Cantwell DP, Schell A, Blaschke T. Growth of hyperactive children treated with stimulants. Arch Gen Psychiatry.1979;36:212\u2013217","DOI":"10.1001\/archpsyc.1979.01780020102011"},{"key":"2021121006145907500_R12","doi-asserted-by":"crossref","unstructured":"Spencer TJ, Biederman J, Harding M, O\u2019Donnell D, Faraone SV, Wilens TE. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?J Am Acad Child Adolesc Psychiatry.1996;35:1460\u20131469","DOI":"10.1097\/00004583-199611000-00014"},{"key":"2021121006145907500_R13","doi-asserted-by":"crossref","unstructured":"MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit\/hyperactivity disorder. Pediatrics.2004;113:754\u2013761","DOI":"10.1542\/peds.113.4.754"},{"key":"2021121006145907500_R14","doi-asserted-by":"crossref","unstructured":"Kraemer H. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry.2002;59:877\u2013883","DOI":"10.1001\/archpsyc.59.10.877"},{"key":"2021121006145907500_R15","unstructured":"Swanson JM. School-Based Assessments and Treatments for ADD Students. Irvine, CA: KC Publishing; 1992"},{"key":"2021121006145907500_R16","unstructured":"Gresham FM, Elliott SN: Social Skills Rating System\u2014Parent, Teacher, and Child Forms. Circle Pines, MN: American Guidance Systems; 1990"},{"key":"2021121006145907500_R17","unstructured":"Wechsler D. Wechsler Individual Achievement Test\u2014Manual. San Antonio, TX: The Psychological Corporation; 1992"},{"key":"2021121006145907500_R18","unstructured":"Hinshaw SP, Owens EB, Wells KC, et al. Family processes and treatment outcome in the MTA: negative\/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol.2000;28:555\u2013568"},{"key":"2021121006145907500_R19","unstructured":"Wells KC, Epstein JN, Hinshaw SP, et al. Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. J Abnorm Child Psychol.2000;28:543\u2013553"},{"key":"2021121006145907500_R20","unstructured":"Marcus S, Gibbons R. Estimating the efficacy of receiving treatment in randomized clinical trials with noncompliance. Health Serv Outcomes Res Method.2002;2:247\u2013258"},{"key":"2021121006145907500_R21","doi-asserted-by":"crossref","unstructured":"Laird NM, Ware JH. Random effect models for longitudinal data. Biometrics.1982;38:963\u2013974","DOI":"10.2307\/2529876"},{"key":"2021121006145907500_R22","doi-asserted-by":"crossref","unstructured":"Bryk AS, Raudenbush SW. Toward a more appropriate conceptualization of research on school effects: a 3-level hierarchical linear model. Am J Educ.1988;97:68\u2013108","DOI":"10.1086\/443913"},{"key":"2021121006145907500_R23","doi-asserted-by":"crossref","unstructured":"Gibbons RD, Hedeker D, Elkin I, et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH Treatment of DCRP dataset. Arch Gen Psychiatry.1993;50:739\u2013750","DOI":"10.1001\/archpsyc.1993.01820210073009"},{"key":"2021121006145907500_R24","doi-asserted-by":"crossref","unstructured":"Hedeker D, Gibbons RD, Flay BR. Random-effects regression models for clustered data with an example from smoking prevention research. J Consult Clin Psychol.1994;62:757\u2013765","DOI":"10.1037\/0022-006X.62.4.757"},{"key":"2021121006145907500_R25","doi-asserted-by":"crossref","unstructured":"Kuo M, Mohler B, Raudenbush SL, Earls FJ. Assessing exposure to violence using multiple informants: application of hierarchical linear model. J Child Psychol Psychiatry.2000;41:1049\u20131056","DOI":"10.1111\/1469-7610.00692"},{"key":"2021121006145907500_R26","doi-asserted-by":"crossref","unstructured":"Pelham WE Jr, Fabiano GA. Behavior modification. Child Adolesc Psychiatr Clin North Am.2000;9:671\u2013688","DOI":"10.1016\/S1056-4993(18)30112-3"},{"key":"2021121006145907500_R27","unstructured":"National Center for Health Statistics, Growth Charts, 2000. Available at: www.cdc.gov\/nchs\/about\/major\/nhanes\/growthcharts\/datafiles.htm"},{"key":"2021121006145907500_R28","doi-asserted-by":"crossref","unstructured":"Kramer JR, Loney J, Ponto LB, Roberts MA, Grossman S. Predictors of adult height and weight in boys treated with methylphenidate for childhood behavior problems. J Am Acad Adolesc Psychiatry.2000;39:517\u2013524","DOI":"10.1097\/00004583-200004000-00022"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/4\/762\/1012862\/zpe00404000762.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/4\/762\/1012862\/zpe00404000762.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T14:09:14Z","timestamp":1639145354000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/113\/4\/762\/63959\/National-Institute-of-Mental-Health-Multimodal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,1]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2004,4,1]]},"published-print":{"date-parts":[[2004,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.113.4.762","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,1]]}}}